Index
Overview
Highlights
Financial framework through 2029
Licensing (Vylor One)
Corn Pipeline
Soybean Pipeline
Gene Editing
Seed operations and route to market
AI
Biofuels and adjacent crops
R&D
M&A
Hybrid Wheat
Related:
Corteva to Spin-Out Seed from Crop Protection and Liabilities - Upstream Ag Professional
Who Get's What in the Vylor and New Corteva Split - Upstream Ag Professional
Overview
Chuck Magro set the tone early for how he wants Vylor to be perceived:
"Over time we will look a lot less like a traditional ag company and more like a biotech or IP driven platform. Over time, this becomes a core earnings driver, a margin expander and a valuation catalyst….We're becoming something different at Vylor, a technology platform built on genetics, powered by AI and monetized through IP."
Vylor is positioning itself as an IP and genetics platform rather than a seed seller, with three specific monetization layers on the germplasm base: branded seed, out-licensing, and gene editing as the science that opens new crops.
They also shared what they see as setting themselves apart from competitors:
Including innovation capabilities:
Which has led to success over the last ~6 years
One of the things that Corteva, and Chuck Magro as CEO, have done is executed consistently which I think instills a lot of confidence in not only investors, but also the entire Vylor team.
Vylor went on to share some details surrounding revenue by region, by crop and surrounding some financial metrics such as expect R&D investment (~$1 Billion annually to start) and EBITDA margins:
Some Highlights
Subscribe to Upstream Ag Professional to read the rest.
Become a paying member of Upstream Ag to get access to this post and other subscriber-only content.
UpgradeA Professional Membership Delivers:
- Subscriber-only insights and deep analysis plus full archive access
- Audio edition for consumption flexibility
- AskUpstream Access, the LLM for serious agribusiness professionals
- Access to the Report Hub and Visualization Hub
